Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Aster DM Healthcare Ltd. Share Price
Day's Range
Day's Range
Low
₹745.50
High
₹759.00
Price Summary
| Previous Close | ₹748.90 |
|---|---|
| Day's Range | ₹745.50 - ₹759.00 |
| Open | ₹759.00 |
| 52 Week Range | ₹519.10 - ₹770.00 |
| Volume | 3,08,190 |
| Market Cap | ₹0.04 |
| Previous Close | ₹747.95 |
|---|---|
| Day's Range | ₹745.80 - ₹761.45 |
| Open | ₹761.45 |
| 52 Week Range | ₹519.80 - ₹769.95 |
| Volume | 13,702 |
| Market Cap | ₹0.04 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 2,308.03 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 100.80 |
| TTM EPS (₹) | 7.49 |
| P/E Ratio | 4.50 |
| Book Value(₹) | 8.55 |
| PAT Margin (%) | 8.14 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 11.46 |
| Trade Value ( ₹ in Lacs) | 102.48 |
|---|---|
| Market Cap (₹ in Mn) | 0.04 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 100.80 |
| TTM EPS (₹) | 7.49 |
| P/E Ratio | 4.50 |
| Book Value(₹) | 8.55 |
| PAT Margin (%) | 8.14 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 11.46 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5738.6 | 41384.6 |
| Expenses | N/A | N/A |
| PBT | 626.0 | 4710.6 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 610.7 | 54078.9 |
About Aster DM Healthcare Ltd.
| Founded | 2008 |
|---|---|
| Managing Director | Azad Moopen |
| NSE Symbol | ASTERDM |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,57,121.30 | 1,882.15 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,81,396.01 | 6,919.65 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,729.85 | 4,457.15 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,331.11 | 8,026.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,15,240.83 | 1,410.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,11,126.23 | 1,333.95 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 1,03,056.40 | 2,477.50 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,03,022.72 | 1,063.55 | 903.00 - 903.00 |
| Lupin Ltd. | 1,03,010.73 | 2,286.50 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 99,737.91 | 1,018.95 | 835.50 - 835.50 |
No Records Found
Latest News
Aster DM Healthcare informs about earnings call
Aster DM Healthcare has informed that the Earnings Call of the Company for the quarter and year ended March 31, 2026, was held on May 01, 2026, and the Video/Audio Recording with respect to Earnings Call is available on the website of the Company at https://www.asterdmhealthcare.in/investors/financial-information/audio-video-recordings-earningsquarterly-calls.
The above information is a part of company’s filings submitted to BSE.
Aster DM Healthcare informs about Nurse Strike at Hospitals in Kerala
Pursuant to Regulation 30 of the LODR Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and in furtherance of our disclosure dated March 14, 2026 on this subject matter, Aster DM Healthcare has informed that it has been extensively engaging with the United Nurses Association over the last few weeks in order to arrive a settlement in relation to the nurses strike across hospitals in Kerala pertaining to their demands for revision in wage structures.
The High Court had directed the United Nurses Association to defer the strike and ensure that its members do not abstain from work or engage in any form of strike or obstruction until March 19, 2026, which was through several oral orders from the Hon’ble High Court has been extended till May 31, 2026. The proceedings continue to be pending with the High Court for a final settlement between the Kerala Private Hospital Association and United Nurses Association.
The company has informed the entire nurse staff in the various Aster hospital units across Kerala, have returned to work and the operations have now resumed in full capacity at all such units.
The above information is a part of company’s filings submitted to BSE.
Aster DM Healthcare informs about press release
Aster DM Healthcare informs about closure of trading window
ln compliance with SEBI (Prohibition of insider Trading) Regulations, 2015, SEBI circular SEBI/HO/ISD/ISDPOD-2/P/CIR/2025/55 dated April 21, 2025 and the ‘Code for Prevention of Insider Trading’ adopted by the Company, Aster DM Healthcare has informed that the Trading Window for dealing in securities of the Company shall be closed for all Designated Persons and their immediate relatives from March 19, 2026 and would be re-opened after 48 hours from the date of declaration of the financial results (standalone and consolidated) of the Company for the quarter and year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Aster DM Healthcare informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Aster DM Healthcare Ltd. is ₹748.90 as of 2026-05-19.
The market capitalisation of Aster DM Healthcare Ltd. is ₹39,123.32 as of 2026-05-18.
The 1-year return of Aster DM Healthcare Ltd. is -6.35% as of 2026-05-19.
The P/E ratio of Aster DM Healthcare Ltd. is 4.50 as of 2026-05-19.
The 52-week high and low of Aster DM Healthcare Ltd. are ₹770.00 and ₹519.10, respectively, as of 2026-05-19.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
